Key Metrics
5.2
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
66
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
0.92
5-Year SI
5-year SI
- N/A 2-year SI
- 0.92 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q2
Oncology
SJR
- Q3 Oncology
- Q2 Pharmacology
- Q3 Cancer Research
- Q2 Medicine (miscellaneous)
- Q2 Radiology, Nuclear Medicine and Imaging
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
0.71
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Topics Covered
- Lung cancer
- Assay
- Breast cancer
- Overall survival
- Western blot
- Hepatocellular carcinoma
- Doxorubicin
- Radioguided Surgery
- Radionuclide
- Gene expression
- Cell cycle
- Hemoglobin
- Clinical significance
- Neuroendocrine tumors
- Albumin
- Colorectal cancer
- Head and neck
- Osteosarcoma
- Immunohistochemistry
- Progression-free survival
Journal Specifications
| Overview | |
| Publisher | MARY ANN LIEBERT, INC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1996 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Cancer Biotherapy and Radiopharmaceuticals ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
<i>Call for Special Issue Papers:</i> Advances in Molecular Medicine
- 8 Feb 24
- Cancer Biotherapy and Radiopharmaceuticals
-
Full paper
Positron Emission Tomography-Based Immunoimaging for Cancer Patient Stratification: Toward a More Holistic Approach
- 1 May 23
- Cancer Biotherapy and Radiopharmaceuticals
-
Full paper
Strategic Clinical Trial Design for Boron Neutron Capture Therapy
- 1 Apr 23
- Cancer Biotherapy and Radiopharmaceuticals
-
Full paper
Neutron Capture Therapy: The Promise of Novel Agents and Medical Facility-Based Neutron Sources
- 1 Apr 23
- Cancer Biotherapy and Radiopharmaceuticals
-
Full paper
<i>Retraction of:</i> Long Noncoding RNA CTD-2589M5.4 Inhibits Ovarian Cancer Cell Proliferation, Migration, and Invasion Via Downregulation of the Extracellular Matrix-Receptor Interaction Pathway (doi: 10.1089/cbr.2020.4429)
- 1 Feb 23
- Cancer Biotherapy and Radiopharmaceuticals
-
Full paper
Acknowledgment of Reviewers 2022
- 1 Feb 23
- Cancer Biotherapy and Radiopharmaceuticals
Scite analysis
Powered by scite_
2.3k articles received 26.3k citations see all
- 899 Supporting
- 24,864 Mentioning
- 78 Contrasting
Editorial notices
- 35 Retractions
- 0 Withdrawals
- 0 Corrections
- 8 Errata
- 0 Expression of Concern
FAQs
How long has Cancer Biotherapy and Radiopharmaceuticals been actively publishing?
Cancer Biotherapy and Radiopharmaceuticals has been in operation since 1996 till date.
What is the publishing frequency of Cancer Biotherapy and Radiopharmaceuticals ?
Cancer Biotherapy and Radiopharmaceuticals published with a Monthly frequency.
How many articles did Cancer Biotherapy and Radiopharmaceuticals publish last years ?
In 2023, Cancer Biotherapy and Radiopharmaceuticals published 5 articles.
What is the eISSN & pISSN for Cancer Biotherapy and Radiopharmaceuticals ?
For Cancer Biotherapy and Radiopharmaceuticals,eISSN is 1557-8852 and pISSN is1084-9785.
What is Citescore for Cancer Biotherapy and Radiopharmaceuticals ?
Citescore for Cancer Biotherapy and Radiopharmaceuticals is 5.2.
What is H index for Cancer Biotherapy and Radiopharmaceuticals ?
H index for Cancer Biotherapy and Radiopharmaceuticals is 66.
What is SNIP score for Cancer Biotherapy and Radiopharmaceuticals ?
SNIP score for Cancer Biotherapy and Radiopharmaceuticals is 0.71.
What is the SJR for Cancer Biotherapy and Radiopharmaceuticals ?
SJR for Cancer Biotherapy and Radiopharmaceuticals is Q2.
Who is the publisher of Cancer Biotherapy and Radiopharmaceuticals ?
MARY ANN LIEBERT, INC is the publisher of Cancer Biotherapy and Radiopharmaceuticals.